This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
3.MN Swartz . Human diseases caused by foodborne pathogens of animal origin. Clinical Infectious Diseases 2002; 34 (Suppl. 3): S111–S122.
4.European Food Safety Authority, European Centre for Disease Prevention and Control. The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2010. EFSA Journal 2012; 10: 2597.
5.JA Haagsma , Disease burden of post-infectious irritable bowel syndrome in The Netherlands. Epidemiology and Infection 2010; 138: 1–7.
6.M Thabane , JK Marshall . Post-infectious irritable bowel syndrome. World Journal of Gastroenterology 2009; 15: 3591–3596.
11.A Gupta , Antimicrobial resistance among Campylobacter strains, United States, 1997–2001. Emerging Infectious Diseases 2004; 10: 1102–1109.
12.RL Guerrant , Practice guidelines for the management of infectious diarrhea. Clinical Infectious Diseases 2001; 32: 331–351.
14.G Kapperud , Clinical features of sporadic Campylobacter infections in Norway. Scandinavian Journal of Infectious Diseases 1992; 24: 741–749.
15.A Ternhag , A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species. Clinical Infectious Diseases 2007; 44: 696–700.
19.J Engberg , Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerging Infectious Diseases 2001; 7: 24–34.
20.A King , I Phillips . A comparison of the in-vitro activity of clarithromycin, a new macrolide antibiotic, with erythromycin and other oral agents. Journal of Hospital Infection 1991; 19 (Suppl. A): 3–9.
22.The Campylobacter Sentinel Surveillance Scheme Collaborators. Ciprofloxacin resistance in Campylobacter jejuni: case-case analysis as a tool for elucidating risks at home and abroad. Journal of Antimicrobial Chemotherapy 2002; 50: 561–568.
24.BK Mandal , Double-blind placebo-controlled trial of erythromycin in the treatment of clinical Campylobacter infection. Journal of Antimicrobial Chemotherapy 1984; 13: 619–623.
33.KE Smith , Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992–1998. New England Journal of Medicine 1999; 340: 1525–1532.
34.JM Nelson , Prolonged diarrhea due to ciprofloxacin-resistant Campylobacter infection. Journal of Infectious Diseases 2004; 190: 1150–1157.
35.J Engberg , Quinolone-resistant Campylobacter infections in Denmark: risk factors and clinical consequences. Emerging Infectious Diseases 2004; 10: 1056–1063.
37.MS Dryden , RJ Gabb , SK Wright . Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. Clinical Infectious Diseases 1996; 22: 1019–1025.
38.BD Kirkpatrick . Infectious diarrhea. In: C Grace , ed. Medical Management of Infectious Disease. New York: Marcel Dekker Inc., 2003, pp. 437.
39.MA Kaplan , Loperamide-simethicone vs loperamide alone, simethicone alone, and placebo in the treatment of acute diarrhea with gas-related abdominal discomfort. A randomized controlled trial. Archives of Family Medicine 1999; 8: 243–248.
40.ST Li , DC Grossman , P Cummings . Loperamide therapy for acute diarrhea in children: systematic review and meta-analysis. PLoS Medicine 2007; 4: e98.